ClassID:

95252

C07D403/12 - page 19 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#5401
20110275612
2011-11-10

Alpha-substituted -sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them

#5402
20110275607
2011-11-10

Nuclear transport modulators and uses thereof

#5403
20110275070
2011-11-10

Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders

#5404
20110274655
2011-11-10

Tetrazolones as inhibitors of fatty acid synthase

#5405
20110274638
2011-11-10

Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics

#5406
20110269770
2011-11-03

Pyrazole compounds for controlling invertebrate pests

#5407
20110269768
2011-11-03

Urotensin II receptor antagonists

#5408
20110269766
2011-11-03

Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses

#5409
20110269760
2011-11-03

2-phenyl pyrazines as tubulin inhibitors

#5410
20110269759
2011-11-03

PYRIMIDINE COMPOUNDS AS DELTA OPIOID RECEPTOR MODULATORS

#5411
20110269745
2011-11-03

6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HTreceptor agonists

#5412
20110269732
2011-11-03

DRUG DISCOVERY METHODS

#5413
20110269696
2011-11-03

Inhibitors of IAP

#5414
20110269244
2011-11-03

LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN

#5415
20110268698
2011-11-03

METHODS FOR TREATING HEPATITIS C

#5416
20110263614
2011-10-27

Novel compounds

#5417
20110263597
2011-10-27

SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY

#5418
20110263572
2011-10-27

3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists

#5419
20110263565
2011-10-27

Compounds

#5420
20110263559
2011-10-27

Indazole compounds useful as ketohexokinase inhibitors

#5421
20110263558
2011-10-27

Azetidines as MEK inhibitors for the treatment of proliferative diseases

#5422
20110263548
2011-10-27

Pyridone and pyridazone analogues as GPR119 modulators

#5423
20110263486
2011-10-27

Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation

#5424
20110257395
2011-10-20

Process for the manufacture of 4-fluoro-2-methyl-1H-indol-5-ol

#5425
20110257211
2011-10-20

Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics

#5426
20110257178
2011-10-20

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#5427
20110257164
2011-10-20

Dipeptidyl peptidase IV inhibitors

#5428
20110257155
2011-10-20

Compounds and compositions as protein kinase inhibitors

#5429
20110257154
2011-10-20

Compounds and compositions as protein kinase inhibitors

#5430
20110256129
2011-10-20

Apoptosis promoters

#5431
20110256128
2011-10-20

Triazole compounds as KSP inhibitors

#5432
20110251212
2011-10-13

PIPERAZINE DERIVATIVES

#5433
20110251176
2011-10-13

Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use

#5434
20110251174
2011-10-13

2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS

#5435
20110251171
2011-10-13

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

#5436
20110248254
2011-10-13

Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative

#5437
20110245271
2011-10-06

Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists

#5438
20110245257
2011-10-06

Heterocyclic compounds and their uses

#5439
20110245247
2011-10-06

Small molecule potentiators of metabotropic glutamate receptors

#5440
20110245242
2011-10-06

Heterocyclically Substituted Anilinopyrimides

#5441
20110245232
2011-10-06

Small molecule potentiators of metabotropic glutamate receptors I

#5442
20110245231
2011-10-06

ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE, AND A METHOD FOR OBTAINING AND THE USE OF SAID ACTIVE SUBSTANCE

#5443
20110245230
2011-10-06

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

#5444
20110245225
2011-10-06

Quinazolinamide derivatives

#5445
20110245220
2011-10-06

Compounds and compositions as modulators of GPR119 activity

#5446
20110237907
2011-09-29

Treatment of amyotrophic lateral sclerosis

#5447
20110237794
2011-09-29

Spiro Compounds And Methods Of Use

#5448
20110237783
2011-09-29

Hydrazonopyrazole derivatives and their use as therapeutics

#5449
20110237628
2011-09-29

Cyclopentyl- and cycloheptylpyrazoles

#5450
20110237598
2011-09-29

Pyrimidines

#5451
20110237596
2011-09-29

Heteroaryl-substituted urea modulators of fatty acid amide hydrolase

#5452
20110237587
2011-09-29

1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same

#5453
20110237585
2011-09-29

Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase

#5454
20110237584
2011-09-29

Kynurenine production inhibitor

#5455
20110237576
2011-09-29

2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity

#5456
20110237573
2011-09-29

N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators

#5457
20110237572
2011-09-29

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

#5458
20110237571
2011-09-29

Phthalazine derivatives as inhibitors of protein kinase

#5459
20110230524
2011-09-22

Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases

#5460
20110230505
2011-09-22

Quinazoline inhibitors of BACE 1 and methods of using

#5461
20110230500
2011-09-22

Inhibitors of phosphoinositide dependent kinase 1 (PDK1)

#5462
20110230494
2011-09-22

4,6-disubstituted pyrimidines useful as kinase inhibitors

#5463
20110230489
2011-09-22

s-Triazine compounds, pharmaceutical compositions and methods of using the same

#5464
20110230485
2011-09-22

6-PHENYL-PYRIMIDIN-4-YL-(PHENYLAMINE OR PHENOXY) DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#5465
20110230483
2011-09-22

Pyridine and pyrazine derivative for the treatment of CF

#5466
20110230481
2011-09-22

DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOD OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT

#5467
20110230465
2011-09-22

VIRAL POLYMERASE INHIBITORS

#5468
20110230463
2011-09-22

2H-chromene compound and derivative thereof

#5469
20110230458
2011-09-22

Phenyl-heteroaryl derivatives and methods of use thereof

#5470
20110230445
2011-09-22

Substituted imidazoles useful for treating type II diabetes

#5471
20110224432
2011-09-15

4,6-disubstitued pyrimidines useful as kinase inhibitors

#5472
20110224255
2011-09-15

Tripeptidyl peptidase inhibitors

#5473
20110224230
2011-09-15

Bicyclic dihydroimidazolone CGRP receptor antagonists

#5474
20110224210
2011-09-15

NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS

#5475
20110224189
2011-09-15

Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases

#5476
20110218194
2011-09-08

Heterocyclic aspartyl protease inhibitors

#5477
20110218103
2011-09-08

Fluoroalkyl-substituted 2-amidobenzimidazoles

#5478
20110217300
2011-09-08

Quinazolinone Compounds and Methods of Use Thereof

#5479
20110213003
2011-09-01

Substituted hydroxamic acids and uses thereof

#5480
20110212994
2011-09-01

Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders

#5481
20110212968
2011-09-01

PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES

#5482
20110212962
2011-09-01

p38 MAP kinase inhibitors

#5483
20110212937
2011-09-01

Compounds for the reduction of β-amyloid production

#5484
20110212930
2011-09-01

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

#5485
20110212920
2011-09-01

N-Substituted Benzene Sulfonamides

#5486
20110212077
2011-09-01

Bi-aryl meta-pyrimidine inhibitors of kinases

#5487
20110212054
2011-09-01

THROMBOPOIETIN MIMETICS

#5488
20110207737
2011-08-25

Substituted bicyclic amines for the treatment of diabetes

#5489
20110207736
2011-08-25

COMPOUNDS THAT MODULATE EGFR ACTIVITY AND METHODS FOR TREATING OR PREVENTING CONDITIONS THEREWITH

#5490
20110207720
2011-08-25

Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)

#5491
20110207719
2011-08-25

Anthra [1, 2-d]imidazole-6,11-dione derivatives, preparation method and application thereof

#5492
20110207714
2011-08-25

Serotonin receptor modulators

#5493
20110207712
2011-08-25

Phosphatidylinositol 3-kinase inhibitors and methods of their use

#5494
20110206652
2011-08-25

Methods for treating atherosclerosis

#5495
20110201657
2011-08-18

AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS

#5496
20110201625
2011-08-18

Pyrazine derivatives as ENAC blockers

#5497
20110201616
2011-08-18

Sulfonamide compounds or salts thereof

#5498
20110201592
2011-08-18

Therapeutic oxy-phenyl-aryl compounds and their use

#5499
20110201590
2011-08-18

Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof

#5500
20110200547
2011-08-18

Cosmetic composition, compound and cosmetic treatment method

#5501
20110196011
2011-08-11

Substituted arylpyrazoles

#5502
20110195960
2011-08-11

Inhibitors of c-fms kinase

#5503
20110195024
2011-08-11

Isatin derivatives for use as in vivo imaging agents

#5504
20110190355
2011-08-04

Heterocyclic indazole derivatives

#5505
20110190271
2011-08-04

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

#5506
20110190268
2011-08-04

Benzimidazole linked pyrrolo[2,1-c[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof

#5507
20110190259
2011-08-04

Compounds and compositions as protein kinase inhibitors

#5508
20110190257
2011-08-04

Bicyclic heterocycles as MEK kinase inhibitors

#5509
20110190248
2011-08-04

Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them

#5510
20110189118
2011-08-04

Cosmetic composition, cosmetic treatment method, and compound

#5511
20110184188
2011-07-28

Insecticidal Benzenedicarboxamide Derivative

#5512
20110183987
2011-07-28

Stereoselective synthesis of bicyclic heterocycles

#5513
20110183977
2011-07-28

Benzene, pyridine, and pyridazine derivatives

#5514
20110183972
2011-07-28

Aromatic ring fused triazine derivatives and uses thereof

#5515
20110183961
2011-07-28

AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF

#5516
20110183957
2011-07-28

Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#5517
20110183954
2011-07-28

TRICYCLIC 2,4-DIAMINO-L,3,5-TRIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER AND MYELOPROLIFERATIVE DISORDERS

#5518
20110183946
2011-07-28

Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of Glaucoma

#5519
20110182850
2011-07-28

ORGANIC COMPOUNDS AND THEIR USES

#5520
20110178294
2011-07-21

NOVEL CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND USE

#5521
20110178125
2011-07-21

Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods

#5522
20110178104
2011-07-21

Anti-Heparin Compounds

#5523
20110178092
2011-07-21

HIV-1 Protease Inhibitors

#5524
20110178086
2011-07-21

Adamantyl diamide derivatives and uses of same

#5525
20110178069
2011-07-21

Inhibitors of interleukin-1β converting enzyme

#5526
20110178007
2011-07-21

Spiro-imidazolone derivatives as glucagon receptor antagonists

#5527
20110172428
2011-07-14

METHODS FOR THE PREPARATION OF INDAZOLE-3-CARBOXYLIC ACID AND N-(S)-1-AZABICYCLO[2.2.2]OCT-3-YL-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE SALT

#5528
20110172231
2011-07-14

2,4-diaminopyrimidine derivatives

#5529
20110172212
2011-07-14

AMINE-BASED COMPOUND AND USE THEREOF

#5530
20110172204
2011-07-14

COMPOUNDS AND THEIR USE

#5531
20110171678
2011-07-14

Modified carbocyanine dyes and their conjugates

#5532
20110171175
2011-07-14

INHIBITORS OF SERINE PROTEASES

#5533
20110166354
2011-07-07

Method for producing optically active amino acid derivative

#5534
20110166342
2011-07-07

7-membered ring compound and method of production and pharmaceutical application thereof

#5535
20110166155
2011-07-07

Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators

#5536
20110166140
2011-07-07

NOVEL SULPHONYLPYRROLES

#5537
20110166137
2011-07-07

Substituted naphthalenyl-pyrimidine compounds

#5538
20110166135
2011-07-07

AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE

#5539
20110166120
2011-07-07

Sulfonyl amide derivatives for the treatment of abnormal cell growth

#5540
20110166020
2011-07-07

Imidazole and Triazole Compounds, Use Thereof and Agents Containing Said Compounds

#5541
20110160459
2011-06-30

5-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLINES AS CANNABINOID CB1 RECEPTOR AGONISTS

#5542
20110160225
2011-06-30

COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS

#5543
20110160221
2011-06-30

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

#5544
20110160209
2011-06-30

Substituted pyridazine carboxamide compounds as kinase inhibitor compounds

#5545
20110160202
2011-06-30

Pyrazine compounds as phosphodiesterase 10 inhibitors

#5546
20110160187
2011-06-30

3-aryl-5,6-disubstituted pyridazines

#5547
20110160182
2011-06-30

Pyrazine compounds as phosphodiesterase 10 inhibitors

#5548
20110160181
2011-06-30

Substituted pyrazoline compounds, their preparation and use as medicaments

#5549
20110160178
2011-06-30

Heterosubstituted N-thiolated beta-lactam compounds and methods of use

#5550
20110158971
2011-06-30

Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof

#5551
20110152518
2011-06-23

Cycloalkyl substituted pyrimidinediamine compounds and their uses

#5552
20110152282
2011-06-23

Compounds and compositions as hedgehog pathway inhibitors

#5553
20110152281
2011-06-23

Compounds and method for treatment of cancer

#5554
20110152260
2011-06-23

Indazole derivatives as modulators of interleukin-1 receptor-associated kinase

#5555
20110152250
2011-06-23

Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof

#5556
20110152245
2011-06-23

Substituted benzamides

#5557
20110152237
2011-06-23

Chemical compounds

#5558
20110152236
2011-06-23

AZETIDINE POLYSUBSTITUTED COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOF

#5559
20110150834
2011-06-23

CRTH2 modulators

#5560
20110150819
2011-06-23

Inhibition of bacterial biofilms with imidazole derivatives

#5561
20110144330
2011-06-16

2,4-pyrimidinediamine compounds and their uses

#5562
20110144180
2011-06-16

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#5563
20110144179
2011-06-16

Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors

#5564
20110144161
2011-06-16

1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

#5565
20110144153
2011-06-16

Amide compound

#5566
20110144150
2011-06-16

Bridged bicyclic RHO kinase inhibitor compounds, composition and use

#5567
20110144126
2011-06-16

5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts

#5568
20110144112
2011-06-16

Apoptosis promoters

#5569
20110144110
2011-06-16

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#5570
20110144106
2011-06-16

Cyclopropane indolinone derivatives

#5571
20110144080
2011-06-16

Pyrazole derivatives as protein kinase modulators

#5572
20110144066
2011-06-16

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

#5573
20110144056
2011-06-16

PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH

#5574
20110143445
2011-06-16

Analysis of Amino Acids And Amine-Containing Compounds Using Tagging Reagents and LC-MS Workflow

#5575
20110143387
2011-06-16

Highly water-soluble, cationic luminescent labels

#5576
20110143270
2011-06-16

Azo compound, azo pigment, pigment dispersion, coloring composition, ink for inkjet recording, coloring composition for color filter, color filter, and process for preparing a coloring composition for color filter

#5577
20110142856
2011-06-16

Compound containing basic group and use thereof

#5578
20110136860
2011-06-09

Compounds

#5579
20110136859
2011-06-09

Compounds

#5580
20110136824
2011-06-09

Urotensin II receptor antagonists

#5581
20110136814
2011-06-09

Diazepine and diazocane compounds as MC4 agonists

#5582
20110136807
2011-06-09

Bicyclic compositions and methods for modulating a kinase cascade

#5583
20110136806
2011-06-09

Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof

#5584
20110136796
2011-06-09

IDO inhibitors

#5585
20110136766
2011-06-09

AURORA KINASE INHIBITORS

#5586
20110136764
2011-06-09

Amino pyrimidine anticancer compounds

#5587
20110135668
2011-06-09

Compounds and compositions as protein kinase inhibitors

#5588
20110135604
2011-06-09

Antiviral compounds

#5589
20110130432
2011-06-02

Heterocyclic Carboxamides For Use As Thrombin Inhibitors

#5590
20110130431
2011-06-02

Compounds which modulate the CB2 receptor

#5591
20110130409
2011-06-02

Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

#5592
20110130365
2011-06-02

Fluorinated Heteroaryls

#5593
20110126996
2011-06-02

Composition and process for whitening paper

#5594
20110124669
2011-05-26

Modulators of cellular adhesion

#5595
20110124668
2011-05-26

Indole derivative having, carbamoyl group, ureido group and substituted oxy group

#5596
20110124637
2011-05-26

Benzimidazoles and related analogs as sirtuin modulators

#5597
20110124626
2011-05-26

BENZAZEPINE DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS

#5598
20110124625
2011-05-26

Modulators of cellular adhesion

#5599
20110118459
2011-05-19

High performance luminescent compounds

#5600
20110118321
2011-05-19

CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES

#5601
20110118280
2011-05-19

Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof

#5602
20110118252
2011-05-19

Substituted amide derivatives and methods of use

#5603
20110118236
2011-05-19

HETEROCYCLIC COMPOUND

#5604
20110117081
2011-05-19

FUNCTIONALIZED PYRROLIDINES AND USE THEREOF AS IAP INHIBITORS

#5605
20110117073
2011-05-19

Protein kinase conjugates and inhibitors

#5606
20110112158
2011-05-12

BENZISOXAZOLE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS

#5607
20110112154
2011-05-12

Heterocyclic sulfonamides

#5608
20110112096
2011-05-12

Pyrimidine derivatives as kinase inhibitors

#5609
20110112095
2011-05-12

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

#5610
20110112091
2011-05-12

DERIVATIVES OF TETRABROMOBENZIMIDAZOLE, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, A METHOF OF USING THE SAME, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES, AND SERINE/THREONINE KINASES MODULATING AGENT

#5611
20110112088
2011-05-12

Pyrazoles for the treatment of obesity and other CNS disorders

#5612
20110112080
2011-05-12

Oxazoline derivatives

#5613
20110112063
2011-05-12

Pyrimidine derivatives as kinase inhibitors

#5614
20110112062
2011-05-12

Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1

#5615
20110112061
2011-05-12

Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity

#5616
20110112060
2011-05-12

1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

#5617
20110112058
2011-05-12

Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer

#5618
20110112051
2011-05-12

Dipeptidyl peptidase-IV inhibitors

#5619
20110108767
2011-05-12

COMPOSITION, AND LIGHT-EMISSION ELEMENT PRODUCED BY USING THE COMPOSITION

#5620
20110108766
2011-05-12

PHOSPHORESCENT LIGHT-EMITTING COMPOSITION AND LIGHT-EMITTING ELEMENT COMPRISING THE COMPOSITION

#5621
20110105597
2011-05-05

Modulation of pathogenicity

#5622
20110105572
2011-05-05

CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS

#5623
20110105568
2011-05-05

Method for the production of sulphonylpyrroles as HDAC inhibitors

#5624
20110105526
2011-05-05

Selective subtype alpha 2 adrenergic agents and methods for use thereof

#5625
20110105520
2011-05-05

Pyrimidine compounds as delta opioid receptor modulators

#5626
20110105508
2011-05-05

Quinoxaline and quinoline derivatives as kinase inhibitors

#5627
20110105472
2011-05-05

Diaminopyrimidines as crop protection agents

#5628
20110105460
2011-05-05

Triazole derivative or salt thereof

#5629
20110105456
2011-05-05

3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#5630
20110105455
2011-05-05

Phenoxy-substituted pyrimidines as opioid receptor modulators

#5631
20110105447
2011-05-05

Modulators of calcium release-activated calcium channel

#5632
20110105440
2011-05-05

Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators

#5633
20110104115
2011-05-05

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

#5634
20110098310
2011-04-28

Amino substituted pyrazines as inhibitors or protein kinases

#5635
20110098299
2011-04-28

Spirolactam derivatives and uses of same

#5636
20110098288
2011-04-28

SULFONAMIDES AS ZAP-70 INHIBITORS

#5637
20110098280
2011-04-28

2,4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS

#5638
20110098277
2011-04-28

Fab I inhibitors

#5639
20110098269
2011-04-28

Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands

#5640
20110098247
2011-04-28

Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors

#5641
20110094694
2011-04-28

Fluorescent whitening agent compositions

#5642
20110092526
2011-04-21

Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826

#5643
20110092512
2011-04-21

HSL inhibitors useful in the treatment of diabetes

#5644
20110092506
2011-04-21

Trisubstituted amine compound

#5645
20110092476
2011-04-21

Bicycloheteroaryl compounds as P2X7 modulators and uses thereof

#5646
20110086897
2011-04-14

(E)-N-(2-amino-phenyl)-3-{1-[4-(l-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts

#5647
20110086889
2011-04-14

TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

#5648
20110086856
2011-04-14

COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES

#5649
20110086854
2011-04-14

N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions

#5650
20110086853
2011-04-14

Therapeutic Compounds

#5651
20110086842
2011-04-14

Pyrimidines as PLK inhibitors

#5652
20110086759
2011-04-14

CHEMICAL COMPOUNDS

#5653
20110086185
2011-04-14

Polymerizable liquid crystal compound and its polymer

#5654
20110082163
2011-04-07

Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity

#5655
20110082153
2011-04-07

Gamma secretase modulators

#5656
20110082151
2011-04-07

SULFONYLUREA MODULATORS OF ENDOTHELIN RECEPTOR

#5657
20110082144
2011-04-07

N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes

#5658
20110082134
2011-04-07

1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia

#5659
20110082131
2011-04-07

Triazole derivatives useful as Axl inhibitors

#5660
20110077399
2011-03-31

Substituted Azole Derivatives as Therapeutic Agents

#5661
20110077290
2011-03-31

Heterocyclic compounds and thrombopoietin receptor activators

#5662
20110077273
2011-03-31

Benzimidazole derivatives

#5663
20110077249
2011-03-31

1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives

#5664
20110077246
2011-03-31

Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same

#5665
20110077245
2011-03-31

Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors

#5666
20110077242
2011-03-31

Diaminopyrimidines as P2Xand P2Xantagonists

#5667
20110077241
2011-03-31

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

#5668
20110077236
2011-03-31

Carboxylic acid amides, the preparation thereof and their use as medicaments

#5669
20110077233
2011-03-31

C-Met Modulators and Method of Use

#5670
20110071289
2011-03-24

AMINOPYRAZOLE AMIDE DERIVATIVE

#5671
20110071206
2011-03-24

Modulators of ATP-binding cassette transporters

#5672
20110071194
2011-03-24

Chemical compounds 572

#5673
20110071175
2011-03-24

Indoles and their therapeutic use

#5674
20110071158
2011-03-24

NEW COMPOUNDS

#5675
20110071154
2011-03-24

Substituted benzothiazoles as orexin antagonists

#5676
20110071152
2011-03-24

5-membered heterocycle-based p38 kinase inhibitors

#5677
20110071149
2011-03-24

Selective kinase inhibitors

#5678
20110071146
2011-03-24

17BetaHSD Type 5 Inhibitor

#5679
20110071144
2011-03-24

QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#5680
20110071125
2011-03-24

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

#5681
20110071074
2011-03-24

Deuterated hepatitis C protease inhibitors

#5682
20110065768
2011-03-17

Non-steroidal androgens compounds

#5683
20110065734
2011-03-17

NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES

#5684
20110065725
2011-03-17

TRIAZOLE AMIDE DERIVATIVES FOR USE IN THERAPY

#5685
20110065713
2011-03-17

Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors

#5686
20110065706
2011-03-17

Therapeutic Agents 812

#5687
20110065704
2011-03-17

Compounds for modulating RNA binding proteins and uses therefor

#5688
20110065702
2011-03-17

Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer

#5689
20110065684
2011-03-17

Phthalazine derivatives as PARP inhibitors

#5690
20110065681
2011-03-17

Amide compounds, compositions and uses thereof

#5691
20110065668
2011-03-17

Phenylpyrazole derivatives

#5692
20110065667
2011-03-17

Phenylpyrazole derivatives

#5693
20110065162
2011-03-17

IRE-1α inhibitors

#5694
20110064892
2011-03-17

Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base

#5695
20110064696
2011-03-17

Hepatitis C virus inhibitors

#5696
20110064695
2011-03-17

Hepatitis C virus inhibitors

#5697
20110060141
2011-03-10

Regioselective preparation of substituted pyrimidines

#5698
20110060024
2011-03-10

Modulators of ATP-binding cassette transporters

#5699
20110059989
2011-03-10

3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases

#5700
20110059987
2011-03-10

Co-crystals and pharmaceutical compositions comprising the same